CWAM
LOXO

Columbia Wanger Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Columbia Wanger Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$38.4M Sell
455,685
-78,594
-15% -$6.55M 0.57% 72
2017
Q3 		$49.2M Buy
+534,279
New +$41.5M 0.73% 46

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Columbia Wanger Asset Management's LOXO Position: Q4 2017 in Review

Columbia Wanger Asset Management reduced its Loxo Oncology, Inc (LOXO) stake by 15% in Q4 2017, selling an estimated $6.55M and leaving 455,685 shares worth $38.4M. The position accounts for 0.57% of the portfolio, ranked #72.

Columbia Wanger Asset Management first reported a position in LOXO in Q3 2017 and has held it in 2 quarters since. The position peaked at $49.2M in Q3 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • Columbia Wanger Asset Management held 455,685 shares of Loxo Oncology, Inc worth $38.4M as of Q4 2017.
  • Columbia Wanger Asset Management sold 78,594 Loxo Oncology, Inc shares in Q4 2017, an estimated $6.55M.
  • Loxo Oncology, Inc made up 0.57% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #72 holding.
  • Columbia Wanger Asset Management first reported a position in Loxo Oncology, Inc in Q3 2017 and has held it in 2 quarters since.
  • Columbia Wanger Asset Management's Loxo Oncology, Inc position peaked at $49.2M in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.